A detailed history of Murchinson Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Murchinson Ltd. holds 83,795 shares of CYTK stock, worth $4.07 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
83,795
Previous 83,795 -0.0%
Holding current value
$4.07 Million
Previous $4.54 Million 2.56%
% of portfolio
1.29%
Previous 0.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$47.86 - $75.05 $1.79 Million - $2.81 Million
37,415 Added 80.67%
83,795 $4.54 Million
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $2.99 Million - $4.68 Million
-62,415 Reduced 57.37%
46,380 $2.51 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $2.51 Million - $4.25 Million
39,356 Added 56.68%
108,795 $7.63 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $1.87 Million - $5.8 Million
69,439 New
69,439 $5.8 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.57B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Murchinson Ltd. Portfolio

Follow Murchinson Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Murchinson Ltd. with notifications on news.